Results 131 to 140 of about 59,458 (179)
Evidence-based consensus guidelines for the pharmacological management of substance dependence: Recommendations from the British Association for Psychopharmacology. [PDF]
Sinclair JMA +20 more
europepmc +1 more source
Alternative Reinforcers Enhance the Effects of Opioid Antagonists, but Not Agonists, on Oxycodone Choice Self-Administration in Nonhuman Primates. [PDF]
de Moura FB, Kohut SJ.
europepmc +1 more source
A phase III clinical trial of PXT3003 in Chinese patients with Charcot-Marie-Tooth disease type 1A. [PDF]
Liu X +29 more
europepmc +1 more source
Postmarketing Research for Opioid Abuse-Deterrent Formulations: A Narrative Review. [PDF]
Webster L, Gudin J, Green JL, Argoff CE.
europepmc +1 more source
Mechanistic Insights into G Protein-Biased κ-Opioid Receptor Signaling Using Dual-Charged Naltrexamine Amides. [PDF]
Doering NP +10 more
europepmc +1 more source
AbstractRationaleMethadone and buprenorphine are among the most widely employed pharmacological treatments currently available for opioid addiction. Cognitive effects of buprenorphine in abstinent heroin abusers are nevertheless far from being understood.MethodsNeuropsychological performance of 18 buprenorphine‐maintained patients (BMP) was evaluated ...
Lambros Messinis, Vasileios Georgiou
exaly +4 more sources

